FAKTOR-OPTIONSSCHEIN - MERCK & CO. Stock

Certificat

DE000MG1SPR9

Market Closed - Bid/Ask 02:49:38 2024-06-11 pm EDT After market 03:16:46 pm
9.48 EUR -0.42% Intraday chart for FAKTOR-OPTIONSSCHEIN - MERCK & CO. 9.455 -0.26%
Current month-13.53%
1 month-4.23%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-11 9.48 -0.42%
24-06-10 9.52 -1.24%
24-06-07 9.64 -0.72%
24-06-06 9.71 -1.22%
24-06-05 9.83 -1.50%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 02:49 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MG1SPR
ISINDE000MG1SPR9
Date issued 2024-04-05
Strike 175.3 $
Maturity Unlimited
Parity 4.28 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.48
Lowest since issue 9.31
Spread 0.01
Spread %0.11%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5 USD
Average target price
142.7 USD
Spread / Average Target
+8.51%
Consensus